The Prostate

Cover image for Vol. 74 Issue 12

September 2014

Volume 74, Issue 12

Pages 1161–1249

  1. Original Articles

    1. Top of page
    2. Original Articles
    3. Erratum
    1. TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer (pages 1161–1170)

      Isabel Drake, Peter Wallström, George Hindy, Ulrika Ericson, Bo Gullberg, Anders Bjartell, Emily Sonestedt, Marju Orho-Melander and Elisabet Wirfält

      Version of Record online: 24 JUN 2014 | DOI: 10.1002/pros.22832

    2. A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis (pages 1171–1182)

      Nadia Ashour, Javier C. Angulo, Guillermo Andrés, Raúl Alelú, Ana González-Corpas, María V. Toledo, José M. Rodríguez-Barbero, Jose I. López, Manuel Sánchez-Chapado and Santiago Ropero

      Version of Record online: 24 JUN 2014 | DOI: 10.1002/pros.22833

    3. Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis (pages 1183–1188)

      Ahmed Elshafei, Ganesh Kartha, Yonghong Li, Ayman S. Moussa, Asmaa Hatem, Tianming Gao and J. Stephen Jones

      Version of Record online: 24 JUN 2014 | DOI: 10.1002/pros.22834

    4. Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways (pages 1189–1198)

      Cátia V. Vaz, Cláudio J. Maia, Ricardo Marques, Inês M. Gomes, Sara Correia, Marco G. Alves, José E. Cavaco, Pedro F. Oliveira and Sílvia Socorro

      Version of Record online: 29 JUN 2014 | DOI: 10.1002/pros.22835

    5. Frequent discordance between ERG gene rearrangement and ERG protein expression in a rapid autopsy cohort of patients with lethal, metastatic, castration-resistant prostate cancer (pages 1199–1208)

      Aaron M. Udager, Yang Shi, Scott A. Tomlins, Ajjai Alva, Javed Siddiqui, Xuhong Cao, Kenneth J. Pienta, Hui Jiang, Arul M. Chinnaiyan and Rohit Mehra

      Version of Record online: 7 JUL 2014 | DOI: 10.1002/pros.22836

    6. KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment (pages 1222–1230)

      Siebren Dijkstra, Gisele H. J. M. Leyten, Sander A. Jannink, Hans de Jong, Peter F. A. Mulders, Inge M. van Oort and Jack A. Schalken

      Version of Record online: 7 JUL 2014 | DOI: 10.1002/pros.22839

    7. Expression of phosphorylated-mTOR during the development of prostate cancer (pages 1231–1239)

      Sarah I.M. Sutherland, Ruth Pe Benito, Susan M. Henshall, Lisa G. Horvath and James G. Kench

      Version of Record online: 7 JUL 2014 | DOI: 10.1002/pros.22840

  2. Erratum

    1. Top of page
    2. Original Articles
    3. Erratum
    1. You have free access to this content
      Erratum (page 1249)

      Version of Record online: 17 JUL 2014 | DOI: 10.1002/pros.22856

      This article corrects:

      A novel canine model for prostate cancer

      Vol. 73, Issue 9, 952–959, Version of Record online: 17 JAN 2013